Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF‐κB and NLRP3 Signaling Pathways
Journal of Biochemical and Molecular Toxicology · 2026-08 · 40 (8)
DOI: 10.1002/jbt.71058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 03.08.2026. Verfasst von Yongmei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dongguan Key Laboratory of Precision Drug Individualized Therapy, Department of Clinical Pharmacy, The Affiliated Dongguan Songshan Lake Central Hosp…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Hyperuricemia, Signal Transduction. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science and Technology Research Foundation of Guangdong, National Nature Science Foundation of China, Special Project for Clinical and Basic Sci&Tech Innovation of Guangdong Medical University.
Abstract (Originalsprache)
Hyperuricaemia (HUA) is a recognized risk factor for cardiovascular and renal diseases. Isobavachin, a dihydroflavone derivative, demonstrates significant efficacy in reducing uric acid levels. This study investigated the nephroprotective and cardioprotective effects and molecular mechanisms of isobavachin. Through integrative network pharmacology, pathway enrichment analysis, and molecular docking, NF‐κB was identified as a potential target of isobavachin in the context of hyperuricemia‐related cardiac and renal injury. Isobavachin treatment inhibited the activation of the NF‐κB pathway, leading to cytoprotection in uric acid (UA)‐stimulated mRTEC and H9C2 cells. In chronic HUA mice, isobavachin treatment significantly improved renal pathology and reduced renal collagen deposition by inhibiting epithelial‐to‐mesenchymal transition. Isobavachin administration demonstrated therapeutic efficacy in attenuating myocardial injury, hypertrophy, and fibrotic remodeling. Notably, the anti‐inflammatory effects of isobavachin were particularly evident in both renal and cardiac tissues, primarily mediated through its dual regulatory capacity in suppressing NF‐κB pathway activation and NLRP3 inflammasome formation. In conclusion, isobavachin ameliorated cardiac and renal damage caused by chronic HUA, suggesting a new strategy to prevent HUA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dongguan Key Laboratory of Precision Drug Individualized Therapy, Department of Clinical Pharmacy, The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China.
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
ORCID-Profile: Jianxin Pang, Ting Wu
Förderung
- Medical Science and Technology Research Foundation of Guangdong
- National Nature Science Foundation of China
- Special Project for Clinical and Basic Sci&Tech Innovation of Guangdong Medical University
- Guangdong Natural Science Foundation
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, Y., Xu, Y., Ye, W., Yu, Z., Wu, Z., Liu, X., Huang, X., Pang, J., Zhao, Z., & Wu, T. (2026). Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF‐κB and NLRP3 Signaling Pathways. Journal of Biochemical and Molecular Toxicology, 40(8). https://doi.org/10.1002/jbt.71058
Vancouver
Li Y, Xu Y, Ye W, Yu Z, Wu Z, Liu X, et al. Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF‐κB and NLRP3 Signaling Pathways. Journal of Biochemical and Molecular Toxicology. 2026;40(8). doi:10.1002/jbt.71058
BibTeX
@article{Li2026,
author = {Li, Yongmei and Xu, Yuexin and Ye, Wenjie and Yu, Zeqi and Wu, Zhenkun and Liu, Xinyi and Huang, Xuhong and Pang, Jianxin and Zhao, Zean and Wu, Ting},
title = {Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF‐κB and NLRP3 Signaling Pathways},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/jbt.71058}
}
EUVIMED